Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Sells 188 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath sold 188 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the sale, the chief financial officer now owns 7,162 shares of the company’s stock, valued at approximately $4,060,424.28. This trade represents a 2.56 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Jamie Samath also recently made the following trade(s):

• On Monday, February 10th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The stock was sold at an average price of $590.00, for a total value of $158,710.00.
• On Wednesday, January 29th, Jamie Samath sold 94 shares of Intuitive Surgical stock. The stock was sold at an average price of $571.11, for a total value of $53,684.34.
• On Tuesday, December 10th, Jamie Samath sold 270 shares of Intuitive Surgical stock. The stock was sold at an average price of $540.15, for a total value of $145,840.50.

Intuitive Surgical Stock Up 1.8 %

Shares of NASDAQ ISRG opened at $568.02 on Thursday. The firm has a market cap of $202.32 billion, a price-to-earnings ratio of 88.61, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The business’s 50 day moving average is $571.70 and its two-hundred day moving average is $530.90.

Institutional Trading of Intuitive Surgical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ISRG. Howard Capital Management Group LLC raised its position in Intuitive Surgical by 4.5% in the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after purchasing an additional 92 shares during the period. Focus Financial Network Inc. increased its position in shares of Intuitive Surgical by 14.4% during the third quarter. Focus Financial Network Inc. now owns 1,273 shares of the medical equipment provider’s stock worth $626,000 after acquiring an additional 160 shares during the period. Farther Finance Advisors LLC increased its position in shares of Intuitive Surgical by 35.1% during the third quarter. Farther Finance Advisors LLC now owns 2,900 shares of the medical equipment provider’s stock worth $1,425,000 after acquiring an additional 754 shares during the period. Chicago Partners Investment Group LLC increased its position in shares of Intuitive Surgical by 1.4% during the third quarter. Chicago Partners Investment Group LLC now owns 2,461 shares of the medical equipment provider’s stock worth $1,261,000 after acquiring an additional 33 shares during the period. Finally, Clear Creek Financial Management LLC increased its position in shares of Intuitive Surgical by 4.4% during the third quarter. Clear Creek Financial Management LLC now owns 1,551 shares of the medical equipment provider’s stock worth $762,000 after acquiring an additional 66 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. BTIG Research boosted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.